Lifecore Biomedical
IPOSterile Injectable CDMO & Sodium Hyaluronate Producer
Public · United States · $24.3M raised
- Headquarters
- Minnesota
- Business Model
- B2B
- Website
- lifecore.com
- Total Funding
- $24.3M
- Last Round
- $24.3M Venture RoundOct 2024
- Rounds
- 1
- Type
- Public
About
CDMO and sodium hyaluronate producer specializing in sterile injectable drug product manufacturing for clinical and commercial use.
Summary
Lifecore Biomedical is a Biotech company based in United States. It has raised $24.3M in total across 1 round, most recently a $24.3M Venture Round round in Oct 2024. Investors include BMO Capital Markets.
Tech & App Stack
3 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2024
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company